Home  >  Products  >  BAG1 (BCL2-associated athanogene ) Blocking Peptide (the N terminal of BAG1)(100ug)
BAG1 (BCL2-associated athanogene ) Blocking Peptide (the N terminal of BAG1)(100ug)

BAG1 (BCL2-associated athanogene ) Blocking Peptide (the N terminal of BAG1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BAG1 Antibody (ARP63477_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63477
Size: 100ug
Weight: 25kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The oncogene BCL2 is a membrane protein that blocks a step in a pathway leading to apoptosis or programmed cell death. The protein encoded by this gene binds to BCL2 and is referred to as BCL2-associated athanogene. It enhances the anti-apoptotic effects of BCL2 and represents a link between growth factor receptors and anti-apoptotic mechanisms. Multiple protein isoforms are encoded by this mRNA through the use of a non-AUG (CUG) initiation codon, and three alternative downstream AUG initiation codons. A related pseudogene has been defined on chromosome X.
Alternative names: HAP; RAP46
See Full Product Listings >